Kodak's Balance Sheet Crisis Is Over - The Market Hasn't Caught Up

The market is still pricing Kodak as a solvency story waiting to break. AInvest's aggregate signal labels the stock Underperform. One fair-value model on Simply Wall St puts the stock at $3.89 - a number that makes sense if you're pricing a company that might default. That was the old story. The balance sheet no longer supports it.

Kodak reported its fourth consecutive quarter of year-over-year improvement on August 4. Revenue rose 18% to $311 million in Q2 2026. Gross profit jumped 61% to $82 million, pushing margins from 19% to 26%. Operational EBITDA... surged 300% to $36 million from $9 million a year earlier. The company turned a GAAP net loss of $26 million in Q2 2025 into net income of $17 million.

The headline number that changes the framing is the debt-to-EBITDA ratio. It stood at 23 times a year ago. Management says it is now 1. That is the difference between a company fighting for its life and one that has breathing room.

The pension reversion that killed the debt

You can't read these quarters without understanding what happened in late 2025. Kodak terminated its overfunded Retirement Income Plan and reversed roughly $767 million in assets back to the company. About $312 million went straight to debt prepayment. That one move eliminated the going-concern warning, slashed interest expense by roughly $40 million annually, and left Kodak with $337 million in cash at year-end.

The point is not that the pension reversion is repeatable. It isn't. The point is that the solvency overhang - the fear that Kodak couldn't service its debt - has been mechanically removed. S&P Global revised the outlook to stable in April. The risk event that anchored the stock for months is gone.

AM&C is the engine. Print is the weight.

Kodak has two businesses, and they are moving in opposite directions structurally.

Advanced Materials & Chemicals grew 40% year-over-year in Q2 2026, to $105 million, with operational EBITDA of $22 million. That segment generates most of the company's profits on roughly a third of total revenue. The growth is fueled by pricing power, pharmaceutical manufacturing at its cGMP-certified facility, and battery electrode coating work through its partnership with Ateios. Management describes the core competency bluntly: "We are the best in the world at layering and coating. It's just what we do."

Print is 70% of revenue. For the full year 2025, Print revenue declined 3% to $715 million. But the profit trajectory shifted in a way that matters more than the top-line decline. Print's operational EBITDA swung from negative $9 million in Q1 2025 to positive $8 million in Q2 2026 - a $17 million swing in two quarters. Anti-dumping duties on Japanese and Chinese aluminum printing plate imports have created a near-monopoly position for Kodak.

Put together: the growth segment is growing fast, and the declining segment stopped losing money. That combination is the inflection.

Why the market hasn't moved on

Kodak stock closed at $8.93 in regular trading on August 4 after reporting, then added another 12.8% to $9.90 in after-hours activity. The market cap reached roughly $878 million on the back of that move.

Even so, the stock has not rerated. The Underperform rating and sub-$4 fair-value estimate show that institutional framing is still anchored to the going-concern scare. The bankruptcy history, the meme-stock reputation, and the nagging question about whether this momentum is real all keep the discount in place.

That discount is what makes the setup interesting. The operating numbers for the last four quarters are:

• Q3 2025: EBITDA $29M, revenue $269M (+3% YoY)
• Q4 2025: EBITDA $22M, revenue $290M (+9% YoY)
• Q1 2026: EBITDA $15M, revenue $265M (+7% YoY)
• Q2 2026: EBITDA $36M, revenue $311M (+18% YoY)

The trajectory through the first half of 2026 is accelerating, not decelerating. Q2 EBITDA of $36 million is more than double Q1's $15 million on an annualizing basis. Even the conservative read - seasonal softness in Q1, a strong Q2 driven by plant shutdown inventory build - doesn't break the trend. Full-year 2026 operational EBITDA is on track to meaningfully exceed 2025's $62 million.

The financial bridge

Kodak doesn't give formal forward guidance. Management stopped doing that years ago and the practice is typical for smaller, more volatile operators. So there's no revenue target to build on top of. But the EBITDA path is visible.

If operational EBITDA holds near $25–30 million per quarter on average - a number comfortably below Q2's $36 million and only slightly above Q1's $15 million - annualized EBITDA lands around $100–120 million. On a $1 billion market cap, that is a 10–12x multiple. Industrial operators with stable cash flows and minimal debt trade at that range or higher. Kodak has a net cash position of roughly $180 million, and a current ratio of 2.53.

The leverage case, not a growth fairy tale, is what underwrites the potential rerating. The market is pricing a distressed industrial. The numbers are starting to look like a stable one.

What would break it

The biggest risk is structural: Print is still the vast majority of revenue and the secular tailwinds don't reverse the long-term demand decline. If Print's operational EBITDA goes back to negative territory, the AM&C growth won't offset it fast enough. The anti-dumping duty protection is real but not permanent - if the trade environment shifts, the monopoly margin buffer disappears.

Second, the battery coating and pharmaceutical ambitions are early. The Ateios partnership is promising but unproven at scale. Class 2 pharmaceutical certification is planned but not yet achieved. These are options on future growth, not current revenue.

Third, commodity costs - silver prices more than doubled from year-end levels and aluminum remains expensive. The Q2 EBITDA improvement came "despite" higher silver and aluminum costs, according to management. If input costs accelerate further, margin expansion stalls.

The setup

I can be wrong again. Kodak has humbled investors before. But the operating setup is cleaner than the market's pricing reflects. The debt-to-EBITDA collapse from 23x to 1x removed the existential risk. The EBITDA trajectory is accelerating. AM&C is growing at a pace that should force a reassessment of the company's profile as a pure legacy printer.

The tripwire is Print's profitability. If Print's operational EBITDA returns to negative territory for two consecutive quarters, the inflection thesis breaks and the old story resumes. Until then, the financial bridge from distressed to stable is visible on the income statement - it just hasn't registered in the consensus yet.

Discipline over ego. Watch the Print EBITDA. If it stays positive and AM&C keeps growing, the rerating comes from arithmetic, not narrative.